Visiob header.jpg

Mission and Values

2020.11.25_BBI_0508.jpg

Our Mission Statement:

Serving the science of diagnostics. We do this by delivering exceptional products and technologies that people rely on to enjoy a better quality of life. Through innovation, partnership, effective delivery and the collaboration of our people, we constantly strive to help set industry standards, engender trust and build our reputation for excellence

BBI Solutions in numbers

We have served the global diagnostics industry for over 50 years, so you know you’re in safe hands.

60 Years

working with customers and partners to develop and manufacture enzymes

400m

lateral flow tests every year use our gold nanoparticles

5bn

test strips contain our Glucose Oxidase for Blood Glucose Monitoring

15m

assay capacity annually with batch sizes from 5k to 100k

Our Values

These are the practical things BBI believes in. They directly inform the decisions we make and the actions we take as a business.

our values icon

Precision

The way we do things is accurate, careful and efficient. From the way we develop our products, to the way we interact with clients, customers and partners – we work to get it right first time.

our values icon

Partnership

We work as a closely-knit team and value our relationships with other experts and organisations. This gives us the knowledge and resource to get the right results.

our values icon

Empowerment

Our work results in powerful, advanced technologies. We develop these into practical effective commercial products and applications – empowering people to live a better life.

our values icon

Potential

We believe in the potential of innovation and our people. Our business is built on bringing out the best in people – nurturing talent and fulfilling all our ambitions.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox